Results 81 to 90 of about 11,087,757 (202)

Role of DPP-4 inhibitors in the treatment of type 2 Diabetes

, 2014
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a relatively new class of oral anti-hyperglycaemic medication which enhance insulin secretion. They are considered to be a promising drug class that may meet the demands for efficacy in the treatment of type ...
Nguyen, Khanh Minh
core  

Screening Emodin Derivatives as DPP-4 Inhibitor Candidates: In Silico and In Vitro Assessment [PDF]

Diabetes mellitus (DM) is a chronic metabolic disease distinguished by disrupted glucose metabolism, causing elevated blood sugar levels. One of the latest therapeutic strategies involves inhibiting dipeptidyl peptidase-4 (DPP-4) to regulate glucose ...
Syahbirin, Gustini, Sugita, Purwantiningsih, Firdayani, Firdayani, Azkiyah, Dina   +3 more
core   +1 more source

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS

, 2016
Diabetes mellitus (DM) is a chronic disease which caused around 1.5 million deaths in 2012. Type 2 diabetes mellitus (T2DM) accounts for 90% of DM worldwide. The prevalence of T2DM is increasing due to obesity.
Kristin, Erna
core   +1 more source

Sitagliptin a DPP 4 Inhibitor

International Journal for Research Trends and Innovation, 2023
Purvita Laxman waghmodey, Mayur Rajkumar Raut, Manorama Namdev Naiknaware   +2 more
openaire   +1 more source

Lactobacilli possess inhibitory activity against dipeptidyl peptidase-4 (DPP-4)

, 2015
Dipeptidyl peptidase 4 (DPP-4) enzymatically inactivates incretin hormones, and DPP-4 inhibitor drugs are clinically approved therapies for type 2 diabetes.
Panwar, Harsh, Calderwood, Danielle, Green, Brian D., Grover, Sunita, Grant, Irene R.; id_orcid   +4 more
core   +1 more source

Surface Energy Modification of Semi-Random P3HTT-DPP

, 2016
Alkyl solubilizing side chains on conjugated polymers can serve as a handle for modifying polymer properties. Recently, oligo-ether and semifluoro alkyl side chains were utilized to tune the surface energy of random P3HT-based polymers without changing ...
Sangtaik Noh (1565080), Seyma Ekiz (2901596), Jenna B. Howard (1565083), Barry C. Thompson (1565077)   +3 more
core   +1 more source

Alogliptin benzoate for management of type 2 diabetes

Vascular Health and Risk Management, 2015
Yoshifumi Saisho Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan Abstract: Dipeptidyl peptidase-4 (DPP-4) inhibitors, a new class of oral hypoglycemic agents, augment glucose-dependent insulin secretion and suppress ...
Saisho Y
doaj  

Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice. [PDF]

Biomedicines, 2023
Alshamrani AA, Al-Hamamah MA, Albekairi NA, Attia MSM, Ahmad SF, Assiri MA, Ansari MA, Nadeem A, Bakheet SA, Alanazi WA, Attia SM.   +10 more
europepmc   +1 more source

Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

, 2009
Type 2 diabetes mellitus (T2DM) is a global epidemic with increasing impact on individuals and healthcare providers. Available treatments (such as metformin, sulfonylureas, glitazones, and insulin) have proven unsatisfactory in producing a long-lasting ...
Piya, Milan K, Piya, Milan, Piya, Milan K. (R19111), Barnett, Anthony, R. Keith Campbell, Barnett, Anthony H., Tahrani, Abd A., Tahrani, Abd; id_orcid, Joshua J. Neumiller, Barnett, Anthony H, Tahrani, Abd A   +10 more
core   +1 more source

RS3PE Syndrome with Subsequent PMR Caused by Long-Term DPP-4 Inhibitor Use. [PDF]

Eur J Case Rep Intern Med, 2023
Takahashi Y, Deshpande GA, Kanai Y, Seok Yan K, Naito T.   +4 more
europepmc   +1 more source